Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amylyx Pharmaceuticals, Inc.
IPO Date: January 7, 2022
Sector: Healthcare
Industry: Biotech
Market Cap: $723.83M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.51 | 3.46%
Avg Daily Range (30 D): $0.23 | 3.52%
Avg Daily Range (90 D): $0.19 | 3.84%
Institutional Daily Volume
Avg Daily Volume: 1.13M
Avg Daily Volume (30 D): 1.45M
Avg Daily Volume (90 D): 1.02M
Trade Size
Avg Trade Size (Sh.): 95
Avg Trade Size (Sh.) (30 D): 93
Avg Trade Size (Sh.) (90 D): 97
Institutional Trades
Total Inst.Trades: 1,319
Avg Inst. Trade: $1.84M
Avg Inst. Trade (30 D): $2.33M
Avg Inst. Trade (90 D): $2.09M
Avg Inst. Trade Volume: .11M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.34M
Avg Closing Trade (30 D): $3.31M
Avg Closing Trade (90 D): $3.12M
Avg Closing Volume: 151.41K
   
News
Jul 14, 2025 @ 10:26 PM
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
Jul 8, 2025 @ 1:00 AM
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
Oct 18, 2024 @ 11:26 AM
Why Amylyx Pharmaceuticals Stock Was So Healthy Th...
Source: Eric Volkman
May 10, 2024 @ 6:01 PM
Breaking Down Amylyx Pharma: 9 Analysts Share Thei...
Source: Benzinga Insights
May 9, 2024 @ 12:15 PM
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Los...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-3.1 $-.42 $-.54
Diluted EPS $-3.1 $-.42 $-.54
Revenue $ -1.27M $ M $ -.67M
Gross Profit $ $ $ -.67M
Net Income / Loss $ -218.86M $ -35.91M $ -37.55M
Operating Income / Loss $ -230.4M $ -37.8M $ -40.65M
Cost of Revenue $ .01M $ M $ M
Net Cash Flow $ -110.06M $ -17.62M $ 5.56M
PE Ratio